Free Trial
OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Price, News & Analysis

Guided Therapeutics logo
$0.25 +0.02 (+6.38%)
As of 07/25/2025 03:35 PM Eastern

About Guided Therapeutics Stock (OTCMKTS:GTHP)

Key Stats

Today's Range
$0.24
$0.25
50-Day Range
$0.13
$0.28
52-Week Range
$0.06
$0.32
Volume
213 shs
Average Volume
5,913 shs
Market Capitalization
$20.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guided Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

GTHP MarketRank™: 

Guided Therapeutics scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Guided Therapeutics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Guided Therapeutics is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Guided Therapeutics is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Guided Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of Guided Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Guided Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Guided Therapeutics has recently decreased by 24.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Guided Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Guided Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the float of Guided Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Guided Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Guided Therapeutics has recently decreased by 24.24%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Guided Therapeutics this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Guided Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    66.83% of the stock of Guided Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 9.69% of the stock of Guided Therapeutics is held by institutions.

  • Read more about Guided Therapeutics' insider trading history.
Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GTHP Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

GTHP Stock Analysis - Frequently Asked Questions

Guided Therapeutics' stock was trading at $0.15 at the beginning of 2025. Since then, GTHP stock has increased by 66.7% and is now trading at $0.25.

Guided Therapeutics Inc. (OTCMKTS:GTHP) posted its quarterly earnings results on Thursday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter.

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guided Therapeutics investors own include Cornerstone Strategic Investment Fund (CLM), Intel (INTC), Beam Therapeutics (BEAM), ChargePoint (CHPT), CSX (CSX), Warner Bros. Discovery (DISCA) and Enbridge (ENB).

Company Calendar

Last Earnings
5/15/2025
Today
7/26/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:GTHP
CIK
924515
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.42 million
Net Margins
N/A
Pretax Margin
-244,200.00%
Return on Equity
N/A
Return on Assets
-197.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.14
Quick Ratio
0.03

Sales & Book Value

Annual Sales
$10 thousand
Price / Sales
2,007.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-2.08

Miscellaneous

Outstanding Shares
80,284,000
Free Float
26,630,000
Market Cap
$20.07 million
Optionable
Not Optionable
Beta
0.11
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:GTHP) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners